<h2>News Now</h2><table><tr><th>Title</th><th>Content</th><th>URL</th><th>Author</th></tr>
<tr><td><h3>The battle to bring Kenya&#39;s warrior children back to school – a photo essay</h3></td><td><p>Covid closures coincided with an initiation ceremony that has put many on a path out of education and set back years of progress</p></td><td><a href=https://www.theguardian.com/global-development/2020/nov/09/kenya-warrior-children-back-to-school-photo-essay>https://www.theguardian.com/global-development/2020/nov/09/kenya-warrior-children-back-to-school-photo-essay</a></td><td><p>Saskia Houttuin in Samburu</p></td></tr><tr><td><h3>Armed groups target Colombia&#39;s children as reform process slows</h3></td><td><p>For families in the northern province of Cauca, time is running out as drug gangs and guerrilla groups exploit Covid chaos</p></td><td><a href=https://www.theguardian.com/global-development/2020/nov/09/armed-groups-target-colombias-children-as-reform-process-slows>https://www.theguardian.com/global-development/2020/nov/09/armed-groups-target-colombias-children-as-reform-process-slows</a></td><td><p>Christina Noriega</p></td></tr><tr><td><h3>NLD coasting to victory and 2nd term for ASSK as votes counted | Coconuts Yangon</h3></td><td><p>The National League for Democracy says it has already won enough seats to form the next government while the tally from yesterday&#39;s election is still being counted.
Though the Union Election Commission has yet to announce the results, Myo Nyunt, a member of the party&#39;s executive committee this morni...</p></td><td><a href=https://coconuts.co/yangon/news/nld-coasting-to-victory-and-2nd-term-for-assk-as-votes-counted/>https://coconuts.co/yangon/news/nld-coasting-to-victory-and-2nd-term-for-assk-as-votes-counted/</a></td><td><p>@coconutsmedia</p></td></tr><tr><td><h3>Accumulate Divi&#39;s Laboratories; target of Rs 3515: Dolat Capital Market</h3></td><td><p>Dolat Capital Market recommended accumulate rating on Divi&#39;s Laboratories with a target price of Rs 3515 in its research report dated November 08, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/accumulate-divis-laboratories-target-of-rs-3515-dolat-capital-market-6088661.html>https://www.moneycontrol.com/news/business/stocks/accumulate-divis-laboratories-target-of-rs-3515-dolat-capital-market-6088661.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Buy UPL; target of Rs 622 KR Choksey</h3></td><td><p>KR Choksey is bullish on UPL has recommended buy rating on the stock with a target price of Rs 622 in its research report dated November 04, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/buy-upl-target-of-rs-622-kr-choksey-6088601.html>https://www.moneycontrol.com/news/business/stocks/buy-upl-target-of-rs-622-kr-choksey-6088601.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Reduce Balkrishna Industries; target of Rs 1536: Dolat Capital Market</h3></td><td><p>Dolat Capital Market recommended Reduce rating on Balkrishna Industries with a target price of Rs 1536 in its research report dated November 07, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/reduce-balkrishna-industries-target-of-rs-1536-dolat-capital-market-6088651.html>https://www.moneycontrol.com/news/business/stocks/reduce-balkrishna-industries-target-of-rs-1536-dolat-capital-market-6088651.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Buy Bandhan Bank; target of Rs 431 KR Choksey</h3></td><td><p>KR Choksey is bullish on Bandhan Bank has recommended buy rating on the stock with a target price of Rs 431 in its research report dated November 03, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/buy-bandhan-bank-target-of-rs-431-kr-choksey-6088641.html>https://www.moneycontrol.com/news/business/stocks/buy-bandhan-bank-target-of-rs-431-kr-choksey-6088641.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Accumulate Jyothy Labs; target of Rs 163: Geojit</h3></td><td><p>Geojit recommended accumulate rating on Jyothy Labs with a target price of Rs 163 in its research report dated November 06, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/accumulate-jyothy-labs-target-of-rs-163-geojit-6088591.html>https://www.moneycontrol.com/news/business/stocks/accumulate-jyothy-labs-target-of-rs-163-geojit-6088591.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Accumulate Coromandel International; target of Rs 837: Geojit</h3></td><td><p>Geojit recommended accumulate rating on Coromandel International with a target price of Rs 837 in its research report dated November 06, 2020.</p></td><td><a href=https://www.moneycontrol.com/news/business/stocks/accumulate-coromandel-international-target-of-rs-837-geojit-6088611.html>https://www.moneycontrol.com/news/business/stocks/accumulate-coromandel-international-target-of-rs-837-geojit-6088611.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Virgin Hyperloop conducts first successful human passenger test</h3></td><td><p>Jay Walder, CEO of Virgin Hyperloop told the publication that “no one has done anything close.”</p></td><td><a href=https://www.moneycontrol.com/news/business/virgin-hyperloop-conducts-first-successful-human-passenger-test-6090761.html>https://www.moneycontrol.com/news/business/virgin-hyperloop-conducts-first-successful-human-passenger-test-6090761.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>From &#39;love&#39; to &#39;thug&#39;: Joe Biden win to change US-North Korea dynamic</h3></td><td><p>Donald Trump&#39;s bizarre diplomatic engagement with Pyongyang veered from mutual insults and threats of war to &#34;love letters&#34; and the first ever meeting between a sitting US president and a North Korean leader.</p></td><td><a href=https://www.moneycontrol.com/news/world/from-love-to-thug-joe-biden-win-to-change-us-north-korea-dynamic-6091851.html>https://www.moneycontrol.com/news/world/from-love-to-thug-joe-biden-win-to-change-us-north-korea-dynamic-6091851.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Delhi overtakes Maharashtra, Kerala as highest contributor to new COVID-19 cases</h3></td><td><p>The city has reported the highest daily new cases, also its highest tally so far with 7,745 new cases.</p></td><td><a href=https://www.moneycontrol.com/news/india/delhi-overtakes-maharashtra-kerala-as-highest-contributor-to-new-covid-19-cases-6091911.html>https://www.moneycontrol.com/news/india/delhi-overtakes-maharashtra-kerala-as-highest-contributor-to-new-covid-19-cases-6091911.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Peak power demand expected to touch record 5,400 MW this winter in Delhi</h3></td><td><p>The peak power demand of Delhi in the last winter season was 5,343 MW on January 1, 2020, discoms said.</p></td><td><a href=https://www.moneycontrol.com/news/india/peak-power-demand-expected-to-touch-record-5400-mw-this-winter-in-delhi-6091901.html>https://www.moneycontrol.com/news/india/peak-power-demand-expected-to-touch-record-5400-mw-this-winter-in-delhi-6091901.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Loans to MSMEs: Paytm plans to disburse Rs 1,000 crore by March 21</h3></td><td><p>Under the &#39;Merchant Lending Program&#39; in Paytm for Business app, the company continues to offer collateral-free loans. Its algorithm determines the credit-worthiness of the merchant based on his daily transactions and arrives at a pre-qualified loan offering. </p></td><td><a href=https://www.moneycontrol.com/news/business/loans-to-msmes-paytm-plans-to-disburse-rs-1000-crore-by-march-21-6091721.html>https://www.moneycontrol.com/news/business/loans-to-msmes-paytm-plans-to-disburse-rs-1000-crore-by-march-21-6091721.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Madhya Pradesh bypolls vote count on November 10; Jyotiraditya Scindia, Kamal Nath prestige at stake</h3></td><td><p>The BJP needs to win at least eight of these 28 seats to retain power and attain a simple majority in the 230-member Assembly, whose effective strength is 229.</p></td><td><a href=https://www.moneycontrol.com/news/politics/madhya-pradesh-bypolls-vote-count-on-november-10-jyotiraditya-scindia-kamal-nath-prestige-at-stake-6092181.html>https://www.moneycontrol.com/news/politics/madhya-pradesh-bypolls-vote-count-on-november-10-jyotiraditya-scindia-kamal-nath-prestige-at-stake-6092181.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Lalit Modi&#39;s son Ruchir seeks SFIO, SEBI probes into Godfrey Philips; alleges corporate governance issues</h3></td><td><p>Ruchir Modi also sought a probe by market regulator SEBI into Godfrey Philips India for violations of the listing norms and lack of other corporate governance in the company.</p></td><td><a href=https://www.moneycontrol.com/news/business/lalit-modis-son-ruchir-seeks-sfio-sebi-probes-into-godfrey-philips-alleges-corporate-governance-issues-6091871.html>https://www.moneycontrol.com/news/business/lalit-modis-son-ruchir-seeks-sfio-sebi-probes-into-godfrey-philips-alleges-corporate-governance-issues-6091871.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>Bank of Maharashtra cuts repo-linked lending rate by 15 basis points</h3></td><td><p>“Reduction in RLLR makes our home loan, car loan, gold loan, education loan, personal loan along with MSME loans more attractive and affordable,” bank&#39;&#39;s executive director Hemant Tamta said in a release.</p></td><td><a href=https://www.moneycontrol.com/news/business/bank-of-maharashtra-cuts-repo-linked-lending-rate-by-15-basis-points-6092221.html>https://www.moneycontrol.com/news/business/bank-of-maharashtra-cuts-repo-linked-lending-rate-by-15-basis-points-6092221.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>SEBI orders attachment of bank, demat, MF accounts of Rainbow Industries, directors</h3></td><td><p>The recovery proceedings were initiated against the company and its directors after they failed to comply with SEBI’s order. </p></td><td><a href=https://www.moneycontrol.com/news/business/markets/sebi-orders-attachment-of-bank-demat-mf-accounts-of-rainbow-industries-directors-6092171.html>https://www.moneycontrol.com/news/business/markets/sebi-orders-attachment-of-bank-demat-mf-accounts-of-rainbow-industries-directors-6092171.html</a></td><td><p>@moneycontrolcom</p></td></tr><tr><td><h3>AP Top 25 Reality Check: Big Ten powers down, out of poll</h3></td><td><p>The Big Ten is kind of upside down early in this strange and abbreviated season.</p></td><td><a href=https://www.stltoday.com/sports/ap-top-25-reality-check-big-ten-powers-down-out-of-poll/article_04ad2509-a7e9-5390-8d97-e7bb2da5a234.html>https://www.stltoday.com/sports/ap-top-25-reality-check-big-ten-powers-down-out-of-poll/article_04ad2509-a7e9-5390-8d97-e7bb2da5a234.html</a></td><td><p>RALPH D. RUSSO AP College Football Writer</p></td></tr><tr><td><h3>STAT WATCH: Northwestern yet to give up a point in 2nd half</h3></td><td><p>Northwestern is 3-0 for the first time since 2015 largely because of a defense that&#39;s yet to give up a point after halftime.</p></td><td><a href=https://www.stltoday.com/sports/stat-watch-northwestern-yet-to-give-up-a-point-in-2nd-half/article_47193b69-6d09-587d-8dda-1c5edec98c5f.html>https://www.stltoday.com/sports/stat-watch-northwestern-yet-to-give-up-a-point-in-2nd-half/article_47193b69-6d09-587d-8dda-1c5edec98c5f.html</a></td><td><p>ERIC OLSON AP College Football Writer</p></td></tr><tr><td><h3>On Football: Be prepared or be ready for an unexpected test</h3></td><td><p>Be prepared, or be ready for an unexpected challenge.</p></td><td><a href=https://www.stltoday.com/sports/football/on-football-be-prepared-or-be-ready-for-an-unexpected-test/article_85dd5902-dbae-5e5a-a896-b87260e9f65c.html>https://www.stltoday.com/sports/football/on-football-be-prepared-or-be-ready-for-an-unexpected-test/article_85dd5902-dbae-5e5a-a896-b87260e9f65c.html</a></td><td><p>BARRY WILNER AP Pro Football Writer</p></td></tr><tr><td><h3>Calliditas Therapeutics to host conference call on positive topline results from pivotal phase 3 NefIgArd trial – Company Announcement</h3></td><td><p>STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- On November 8, 2020, Calliditas announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon® versus placebo in patients with primary IgA nephropathy (IgAN). Calliditas will host a telep...</p></td><td><a href=https://markets.ft.com/data/announce/detail?dockey&#61;600-202011090413PR_NEWS_EURO_ND__EN84644-1>https://markets.ft.com/data/announce/detail?dockey=600-202011090413PR_NEWS_EURO_ND__EN84644-1</a></td><td><p>PR Newswire</p></td></tr><tr><td><h3>Aducanumab At The FDA</h3></td><td><p>Time for FDA advisory committee to look at Biogen&#39;s proposed Alzheimer&#39;s therapy, the anti-amyloid antibody aducanumab.</p></td><td><a href=https://seekingalpha.com/article/4386900-aducanumab-fda?source&#61;feed_sector_healthcare>https://seekingalpha.com/article/4386900-aducanumab-fda?source=feed_sector_healthcare</a></td><td><p>Derek Lowe</p></td></tr><tr><td><h3>Cancer biotech IN8bio sets IPO terms</h3></td><td><p></p></td><td><a href=https://seekingalpha.com/news/3633422-cancer-biotech-in8bio-sets-ipo-terms?source&#61;feed_sector_healthcare>https://seekingalpha.com/news/3633422-cancer-biotech-in8bio-sets-ipo-terms?source=feed_sector_healthcare</a></td><td><p>SeekingAlpha.com</p></td></tr><tr><td><h3>Orphazyme submits marketing application for arimoclomol in Europe for rare lipid disorder</h3></td><td><p></p></td><td><a href=https://seekingalpha.com/news/3633423-orphazyme-submits-marketing-application-for-arimoclomol-in-europe-for-rare-lipid-disorder?source&#61;feed_sector_healthcare>https://seekingalpha.com/news/3633423-orphazyme-submits-marketing-application-for-arimoclomol-in-europe-for-rare-lipid-disorder?source=feed_sector_healthcare</a></td><td><p>SeekingAlpha.com</p></td></tr><tr><td><h3>TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call Transcript</h3></td><td><p></p></td><td><a href=https://seekingalpha.com/article/4386911-tff-pharmaceuticals-inc-tffp-ceo-glenn-mattes-on-q3-2020-results-earnings-call-transcript?source&#61;feed_sector_healthcare>https://seekingalpha.com/article/4386911-tff-pharmaceuticals-inc-tffp-ceo-glenn-mattes-on-q3-2020-results-earnings-call-transcript?source=feed_sector_healthcare</a></td><td><p>SeekingAlpha.com</p></td></tr><tr><td><h3>The Sell-Off In Myovant Is Unjustified By Fundamentals (NYSE:MYOV)</h3></td><td><p>Myovant has positive Phase 3 results in all 3 indications for its main drug relugolix. The stock has taken a huge dive based on disappointing results on a secondary endpoint of the relugolix Phase 3 prostate cancer trial.</p></td><td><a href=https://seekingalpha.com/article/4386912-sell-off-in-myovant-is-unjustified-fundamentals?source&#61;feed_sector_healthcare>https://seekingalpha.com/article/4386912-sell-off-in-myovant-is-unjustified-fundamentals?source=feed_sector_healthcare</a></td><td><p>Andy Jones</p></td></tr><tr><td><h3>Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020</h3></td><td><p>STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- BioArctic AB (publ) [Nasdaq Stockholm: BIOA B] announced today data on the drug candidate BAN2401 (lecanemab), which were presented by the company&#39;s partner Eisai at the Clinical Trials on Alzheimer&#39;s Disease conference (CTAD), November 4-7. The presentations ...</p></td><td><a href=http://feeds.benzinga.com/~r/benzinga/news/~3/F0JoT4LbZZE/eisai-presented-latest-data-regarding-drug-candidate-ban2401-at-ctad-2020>http://feeds.benzinga.com/~r/benzinga/news/~3/F0JoT4LbZZE/eisai-presented-latest-data-regarding-drug-candidate-ban2401-at-ctad-2020</a></td><td><p>PRNewswire</p></td></tr><tr><td><h3>Report from cyberbullying expert identifies &#39;negligence&#39; towards student&#39;s wellbeing at Institut Le Rosey</h3></td><td><p>Source: Dr Sameer Hinduja, Co-Director of the Cyberbullying Research Center

A report issued by Dr Hinduja of the Cyberbullying Research Center examines the failings at the world&#39;s most expensive school, Le Rosey, in Switzerland
The report found that the school was &#39;deliberately indifferent&#39; to the ...</p></td><td><a href=http://feeds.benzinga.com/~r/benzinga/news/~3/u9Uj7W46kS4/report-from-cyberbullying-expert-identifies-negligence-towards-students-wellbeing-at-institut-le-r>http://feeds.benzinga.com/~r/benzinga/news/~3/u9Uj7W46kS4/report-from-cyberbullying-expert-identifies-negligence-towards-students-wellbeing-at-institut-le-r</a></td><td><p>Globe Newswire</p></td></tr><tr><td><h3>Another Alibaba-Backed Grocer Suffers Massive Data Breach</h3></td><td><p>In more trouble for the Chinese tech giant, Alibaba Group Holdings Ltd (NYSE: BABA)-backed Indian grocer BigBasket suffered a massive data breach...</p></td><td><a href=https://www.benzinga.com/news/20/11/18266732/another-alibaba-backed-grocer-suffers-massive-data-breach>https://www.benzinga.com/news/20/11/18266732/another-alibaba-backed-grocer-suffers-massive-data-breach</a></td><td><p>Mohit Manghnani</p></td></tr></table>
